TAKE THIS POLL |
|
|
- TV doesn't show my softer side, says Dr Gillian McKeith 17 May 2008 09:06 GMT
... TV doesn't show my softer side, says Dr Gillian McKeith BEING ... 20 years. The number of people getting type two diabetes and heart disease is totally unnecessary. We can ...
- Give Us Our Daily Meds 17 May 2008 07:33 GMT
... adult problems. Medco estimates about 1.2 million American children now are taking pills for Type 2 diabetes, sleeping troubles and gastrointestinal problems such as heartburn. Copyright 2008 Associated Press. All rights reserved. ...
- Dear Jay, a few encouraging words from an old hand at finger sticks 17 May 2008 06:16 GMT
... having diabetes isn't a pain. People always ask the difference between Type 1 and Type 2 diabetes when, hint, they could just go to WebMD. The easy answer is, in Type 1, ...
- Doctors urged to be more aggressive in linking diabetes, heart disease 17 May 2008 04:43 GMT
... heart disease and a diabetic man has twice the risk. *Two-thirds of patients with Type 2 diabetes will die of heart disease. *Forty-four percent of patients admitted to the hospital with heart ...
- Marine Corps League members convene here 17 May 2008 02:19 GMT
... National Academy of Sciences recently determined a high number of Vietnam War veterans contracted type 2 diabetes as a result of exposure to dioxin. "We do all this. We go to school ...
- Phenomix Announces PHX1149 Phase 2b Clinical Trial Results for Type 2 Diabetes 16 May 2008 22:35 GMT
... inhibitor, demonstrated positive results in a Phase 2b clinical trial for the treatment of Type 2 diabetes. The 12-week, double-blind, placebo-controlled clinical trial involving 422 randomized patients compared PHX1149 in once-daily oral ...
- BUYINS.NET: (AMLN) SqueezeTrigger Price is $31.880. There is $742,577,454.90 That Short Sellers Still Need To Cover 16 May 2008 20:59 GMT
... to as exenatide LAR, to enable once-weekly administration of exenatide for the treatment of type 2 diabetes. It also has multiple early-stage programs for diabetes and obesity. The Company began selling BYETTA ...
- Racial Disparities In Diabetes Control Not Solely Linked To Lower Treatment Adherence Among Blacks, Study Finds 16 May 2008 20:22 GMT
... in diabetes control, according to a study published in the journal reports. Blacks with type 2 diabetes tend to have more problems controlling their blood sugar than whites and also are at ...
- Obesity in the U.S. 16 May 2008 19:26 GMT
... Being overweight increases the risk for many types of health problems, like heart disease, type 2 diabetes, stroke, high blood pressure, high cholesterol, osteoarthritis, gallbladder disease, sleep apnea and certain types of ...
- Research links common chemicals to obesity 16 May 2008 19:15 GMT
... 400 million people are obese, a problem that raises the risk of conditions like type 2 diabetes and heart disease. Previous studies have linked these chemicals -- also found in water pipes ...
- Common Drug Eases Leg Pain From Walking 16 May 2008 17:54 GMT
... age 50, according to the U.S. National Heart, Lung, and Blood Institute. People with type 2 diabetes have an especially high risk of PAD and intermittent claudication. While naftidrofuryl can help patients ...
- Yorkers develop battle plan against childhood obesity 16 May 2008 17:54 GMT
... an increased risk of developing orthopedic problems and chronic disease including arthritis, heart disease, type 2 diabetes and sleep apnea. Alvarnaz said excess weight is one of the leading health concerns in ...
- Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Thera 16 May 2008 16:51 GMT
... Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood ...
- Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based Therapy, Significantly 16 May 2008 16:41 GMT
... or sulfonylurea-based therapy, significantly lowers blood glucose (as measured by A1C) in patients with type 2 diabetes mellitus who had failed to achieve glycemic control (ADA target of A1C < 7%). These ...
- Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lo 16 May 2008 16:41 GMT
... Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood ...
- Target Product Profiles 2008: Physician Insights on Key Attributes - Type 2 Diabetes 16 May 2008 13:45 GMT
... 2 Diabetes" to their offering. A weight-neutral oral antidiabetic drug for the treatment of type 2 diabetes. A therapy that is more effective than orlistat at inducing weight loss for the treatment ...
- Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 16 May 2008 13:34 GMT
... First and Only Therapy Approved to Treat Both Type 2 Diabetes and High LDL- Cholesterol Welchol Recently Added to ACE/AACE Road Maps PARSIPPANY, N.J., May 16 ...
- Pittsburgh firefighter sues over suspension for diabetes 16 May 2008 13:34 GMT
... Article Last Updated: 05/16/2008 08:06:17 AM EDT
- Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based The 16 May 2008 13:33 GMT
... Combined With Metformin -- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults With Type 2 Diabetes Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based Therapy, Significantly Lowers ...
- Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults With Type 2 Diabetes 16 May 2008 13:31 GMT
... or sulfonylurea-based therapy, significantly lowers blood glucose (as measured by A1C) in patients with type 2 diabetes mellitus who had failed to achieve glycemic control (ADA target of A1C < 7%). These ...
1 - 25 of 923 next >
News by PR Newswire
|
